Oxygenta Pharma
Key Stats
Revenue
in ₹ Crores
Oxygenta Pharma
Key Stats (Trailing)
EPS
in ₹
Margin
Annual P&L
in Crores
Revenue (TTM)
72
Operating Profit (TTM)
-9
PAT (TTM)
0
EPS (in Rs.) (TTM)
1
Balance Sheet
in Crores
Cash & Bank Balance (2024)
0
Inventories (2024)
14
Total Debt (2024)
57
Adjusted Book Value (in Rs.) (2024)
-6
Cash Flow
in Crores
CF Operating Activities(2024)
-13
CF Investing Activities (2024)
-4
CF Financing Activities (2024)
17
Net Cash Flow (2024)
0
Valuation
P/E (2024)
0.0
P/B (2024)
-4.7
EV/Sales (2024)
3.9
EV/EBITDA (2024)
-16.0
Shareholding
Growth
Net Sales (2024)
28 %
Core EBITDA (2024)
-35 %
PAT (2024)
70 %
EPS (2024)
88 %
Performance
ROA (2024)
-6 %
ROE (2024)
0 %
ROCE (2024)
-41 %
Asset Turnover (2024)
0.7
Financial Stability
Total Debt / Equity (2024)
-2.8
Current Ratio (2024)
0.7
Quick Ratio (2024)
0.3
Interest Cover (2024)
-7.7
Peers
by Market Cap in ₹ Crores
DCF Value
Rs.
Rs.
Rs.
Rs.
Reverse DCF
Rs.
Rs.
Rs.
No related articles found !!!